[Ovid] A Biologic With Otologic Consequences: Analysis of Hearing Loss and Teprotumumab Using the FDA Adverse Event Reporting System |
|
This post will be closed automatically in 2026-11-07 05:09
Reward10points
|
post
reply
points
0
10
Early Experience With the Clinical Use of Teprotumumab in a Heterogenous Thyroid Eye Disease Population
10
A Biologic With Otologic Consequences: Analysis of Hearing Loss and Teprotumumab Using the FDA Adverse Event Reporting System
10
Effects of Teprotumumab on Eyelid Retraction in Thyroid Eye Disease
10
Objective Diplopia Outcomes for Patients Treated With Teprotumumab for Thyroid Eye Disease
10
Teprotumumab and Orbital Decompression for the Management of Proptosis in Patients With Thyroid Eye Disease
